FDA grants Priority Review for ocrelizumab
Researchers image neuroinflammation in MS mouse model
New study links four genes to MS
Study suggests microbleeds, MS disability link
Researchers find sleep apnea, cognitive dysfunction link
New stem cell treatment shows promise in MS
FDA approves Zinbryta for use in MS treatment
Study suggests gene, immune cell deregulation link in MS
Unless otherwise specified, all medical content is compiled by MSF staff and reviewed for accuracy by a member of our Medical Advisory Board.
The MSF strives to present clear and unbiased information. This site is partially funded through a grant from Bayer Healthcare, LLC.
© Copyright 2000-2013 Multiple Sclerosis Foundation - All Rights Reserved